A5102864164- Breast Cancer Treatment Studies
- Breast Lesions and Carcinomas
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Bone health and osteoporosis research
- Colorectal Cancer Screening and Detection
- Cancer Treatment and Pharmacology
- Glioma Diagnosis and Treatment
- Healthcare Policy and Management
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Advanced Breast Cancer Therapies
- Diet and metabolism studies
- Global Cancer Incidence and Screening
- BRCA gene mutations in cancer
- Antiplatelet Therapy and Cardiovascular Diseases
- Vitamin D Research Studies
- Cancer Cells and Metastasis
- Bladder and Urothelial Cancer Treatments
- Cancer and Skin Lesions
- Blood Coagulation and Thrombosis Mechanisms
- Computational Drug Discovery Methods
- Microtubule and mitosis dynamics
- Genetic factors in colorectal cancer
- Multiple Myeloma Research and Treatments
- Cervical Cancer and HPV Research
- Chromatin Remodeling and Cancer
Mayo Clinic Hospital
2025
University of Minnesota
2024
University of Washington
2018-2021
Seattle University
2021
United States Department of the Navy
2019
University of San Diego
2019
Avera McKennan Hospital & University Health Center
2018
Duquesne University
2017
The Christie NHS Foundation Trust
2013
South Australia Pathology
2010
Medulloblastoma (MB) encompasses diverse subgroups, and leptomeningeal disease/metastasis (LMD) plays a substantial role in associated fatalities. Despite extensive exploration of canonical genes MB, the molecular mechanisms underlying LMD involvement orthodenticle homeobox 2 (OTX2) gene, key driver aggressive MB Group 3, remain insufficiently understood. Recognizing OTX2's pivotal role, we investigated its potential as catalyst for cellular behaviors, including migration, invasion,...
Lenalidomide and pomalidomide are two immunomodulatory medications with the potential to improve outcomes for patients multiple myeloma; however, a black box warning venous thromboembolism exists.The purpose of this study was assess overall adherence guideline recommendations anticoagulation therapy lenalidomide in myeloma patients.This retrospective at an ambulatory oncology clinic utilized chart reviews from calendar years 2013-2016. The primary endpoint prescription appropriate upon...
330 Background: Over the last 25-30 years there has been little or no advancement in prognosis treatment of high grade and muscle invasive bladder cancer, with 5 survival rates following radical 40-50%. The aim this project was to develop a validated, data linked tissue microarray (TMA) cystectomy patients for assessment putative biomarkers provision developmental drug pre-screening tool. Methods: All derived FFPE blocks from Christie tertiary cancer centre (1969-2006) were retrieved...
Abstract Background: Different gene expression sets have been reported to reproducibly assess the metastatic potential of early stage operable breast tumors. Knowledge biology-based components amalgamated scores may provide insight into relative contributions cellular processes involved. We sought compare a composite metastasis score (cMS) consisting previously Metastasis Score (MS), that serves essentially as proliferation index, and progesterone receptor (PR) with Oncotype DX® Recurrence...